5-hydroxytryptophan in treatment of moderate to severe OCD
Phase 3
Recruiting
- Conditions
- Obsessive- Cumpulsive Disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT20090117001556N106
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Age between 18-60 years old
Diagnosis of OCD based on DSM-5
inimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale
Exclusion Criteria
Substance dependence
IQ less than 70
Any other mental disorder
Any serious cardiac, renal or hepatic disease
receiving psychotropic medications during the last 6 weeks
pregnancy or breast feeding
Rising liver transaminases to three times the upper limit of normal or higher
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of symptoms of OCD. Timepoint: Baseline and weeks: 4, 8, 12 after beginnig of treatment. Method of measurement: Y_BOCS( Yale-Brown obsessive compulsive scale).
- Secondary Outcome Measures
Name Time Method